Standard Operating Procedure for preparing of the COVID-19 Vaccine Pfizer-BioNTech in PCN designated sites prior to immediate administration.

Information

A standard operating procedure is attached to this page.

These documents may be adapted by Superintendent Pharmacists for the use of the vaccine in Community Pharmacy settings.

You should also familiarise yourself with our background guide Facilitating Pharmaceutical support to PCN Designated Sites for COVID-19 vaccinations.

Attachments

Other handling content for PCNs

Other COVID-19 vaccines resources

Other external resources

COVID-19 Vaccine Pfizer-BioNTech Handling and Preparation Video

A video produced by Pfizer showing the correct handling and preparation of the COVID-19 Vaccine Pfizer-BioNTech

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional in England, get in touch with us if you still have questions

Change history

  1. PVH3 - Amendment of content and scope to include requirements for use of Regulation 174 and licensed Comirnaty products. Removal of waste code table.
  2. PVH3.1 - Amended in line with introduction of licensed Comirnaty product
  3. PVH3.2 - Amended in line with introduction of licensed Comirnaty product
  1. Addition of wording to webpage referring to use within Community Pharmacy settings.
  1. PVH3 - Clarification following update to national PGD, Clarification of disposal route for outer packaging
  1. Link to Pfizer video added
  1. PVH3 - Needle gauge options for morbidly obese amended, avoidance of pooling added and amended to six doses in line with updated regulation 174
  2. PVH3.1 - Amended in line with updated regulation 174
  3. PVH3.2 - Amended in line with updated regulation 174
  1. PVH3.2 - In line with PVH3 version 2.4 update. Minor clarifications and addition of consumables for sixth dose added into main text
  2. PVH3 - 5.4.4 - Word “new” added
  3. PVH3 - 5.4.1 - Additional consumables for sixth dose added
  4. PVH3 - 5.3.1 - Clarification of swab type
  5. PVH3 - 3 - Wording reflects availability of National Protocol
  6. PVH3 - 5.1.7 - Clarification of second check
  1. Published